[ XXXX between 50 and 60. A more than 20-year-long retrospective study. Apropos of 65 case reports].

@entity1 @entity263 @entity5
Sixty five 50 to 60 year old @entity1 have been treated for @entity263 over a 21 year period. Twenty four had a local @entity263 (A1, A2, B1, B2) and 41 (63.2%) a locally advanced or metastatic (D1, D2 disease at diagnosis. The mean age was 56 years old. As being as retrospective study, miscellaneous treatments were done. The 5 and 10 years survival, analysed with the Kaplan-Meier method, was 61% and 31% respectively. According to the stage of @entity5 , the 10 year survival was 72% and 5% for (A-B) and (C-D) respectively. For well differentiated @entity5 , 5 years survival was 67% instead of 36% for undifferentiated ones. The 10 year survival was 36% for well differentiated @entity5 with 6 on 8 @entity1 who survived with a mean of 11.6 ears. The authors discussed the benefit of an early diagnosis of prostatic in the 50-60 year old @entity1 group which is 4% of the total @entity263 diagnosed within the same period. They analysed the influence of PSA and transrectal sonography interest at this age.
